Strata Critical Medical (SRTA)
Strata Critical Medical on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as services-health services.
4.5M
Short interest
settlement 2026-10-15
5.0
Days to cover
-1.1 days vs prior
21.4%
Short share of volume
2026-11-02
1,538
Fails to deliver
settlement 2026-09-11
Mon 9 Nov
Next earnings
estimated date
-$29K
Insider flow, 90 days
0 buys, 1 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 28 settlements in the table, 28 in the chart. JSONAs of 15 October 2026, short interest in SRTA is 4,538,023 shares, up 179,304 shares over the last month. Over the last 28 readings it ranged from 2,138,637 shares (30 September 2025) to 7,824,961 shares (15 June 2026). At the reported average volume of 908K shares a day that is 5.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/srta" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 4,538,023 | +4.8% | 907,656 | 5.00 |
| 2026-09-30 | 4,331,692 | -0.6% | 713,311 | 6.07 |
| 2026-09-15 | 4,358,719 | -3.7% | 844,750 | 5.16 |
| 2026-08-31 | 4,525,352 | +7.9% | 820,057 | 5.52 |
| 2026-08-14 | 4,194,992 | -0.2% | 1,290,425 | 3.25 |
| 2026-07-31 | 4,201,679 | -2.9% | 971,950 | 4.32 |
| 2026-07-15 | 4,327,351 | +6.2% | 963,671 | 4.49 |
| 2026-06-30 | 4,075,056 | -47.9% | 1,622,698 | 2.51 |
| 2026-06-15 | 7,824,961 | +56.8% | 1,087,102 | 7.20 |
| 2026-05-29 | 4,991,225 | -27.4% | 1,043,171 | 4.78 |
| 2026-05-15 | 6,877,454 | +7.5% | 1,156,568 | 5.95 |
| 2026-04-30 | 6,398,485 | +8.3% | 677,080 | 9.45 |
| 2026-04-15 | 5,907,747 | -20.4% | 637,344 | 9.27 |
| 2026-03-31 | 7,422,968 | +12.9% | 687,997 | 10.79 |
| 2026-03-13 | 6,575,479 | +18.4% | 1,037,850 | 6.34 |
| 2026-02-27 | 5,556,017 | -12.9% | 637,975 | 8.71 |
| 2026-02-13 | 6,381,615 | +6.5% | 743,274 | 8.59 |
| 2026-01-30 | 5,991,211 | -0.7% | 950,701 | 6.30 |
| 2026-01-15 | 6,031,295 | +9.4% | 982,184 | 6.14 |
| 2025-12-31 | 5,511,020 | -8.1% | 754,626 | 7.30 |
| 2025-12-15 | 5,998,697 | +8.7% | 894,976 | 6.70 |
| 2025-11-28 | 5,516,979 | +37.9% | 987,252 | 5.59 |
| 2025-11-14 | 3,999,733 | +53.9% | 998,234 | 4.01 |
| 2025-10-31 | 2,599,765 | +8.9% | 589,725 | 4.41 |
| 2025-10-15 | 2,386,125 | +11.6% | 738,643 | 3.23 |
| 2025-09-30 | 2,138,637 | -28.3% | 1,340,492 | 1.60 |
| 2025-09-15 | 2,983,500 | +22.4% | 626,535 | 4.76 |
| 2025-08-29 | 2,437,291 | +17.5% | 647,092 | 3.77 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of SRTA volume is 21.4%, down 33.4 points over the last five sessions. Over the last 30 readings it ranged from 14.7% (29 October 2026) to 77.8% (29 September 2026). The latest reading is 30.6 points below the 30-session average of 52.0%, on 734K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 157K | 734K | 21.4% | 0 |
| 2026-10-30 | 175K | 440K | 39.7% | 0 |
| 2026-10-29 | 83K | 564K | 14.7% | 0 |
| 2026-10-28 | 135K | 356K | 37.9% | 6 |
| 2026-10-27 | 152K | 377K | 40.2% | 150 |
| 2026-10-26 | 91K | 166K | 54.9% | 18 |
| 2026-10-23 | 87K | 141K | 61.5% | 4,412 |
| 2026-10-22 | 101K | 159K | 63.4% | 0 |
| 2026-10-21 | 68K | 125K | 54.6% | 0 |
| 2026-10-20 | 96K | 128K | 75.2% | 370 |
| 2026-10-19 | 321K | 490K | 65.6% | 0 |
| 2026-10-16 | 204K | 390K | 52.3% | 2,211 |
| 2026-10-15 | 118K | 200K | 58.9% | 0 |
| 2026-10-14 | 177K | 294K | 60.2% | 0 |
| 2026-10-13 | 128K | 172K | 74.7% | 0 |
| 2026-10-12 | 133K | 227K | 58.4% | 0 |
| 2026-10-09 | 101K | 189K | 53.2% | 200 |
| 2026-10-08 | 159K | 276K | 57.8% | 9,167 |
| 2026-10-07 | 80K | 191K | 42.1% | 5,513 |
| 2026-10-06 | 122K | 270K | 45.2% | 1,498 |
| 2026-10-05 | 202K | 454K | 44.6% | 0 |
| 2026-10-02 | 247K | 388K | 63.6% | 70,729 |
| 2026-10-01 | 293K | 641K | 45.7% | 5,733 |
| 2026-09-30 | 118K | 228K | 51.8% | 0 |
| 2026-09-29 | 362K | 465K | 77.8% | 0 |
| 2026-09-28 | 114K | 187K | 61.2% | 4,483 |
| 2026-09-25 | 82K | 185K | 44.3% | 0 |
| 2026-09-24 | 82K | 171K | 48.1% | 1,020 |
| 2026-09-23 | 124K | 279K | 44.4% | 0 |
| 2026-09-22 | 73K | 157K | 46.6% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 11 September 2026, the fails-to-deliver balance in SRTA is 1,538 shares, up 1,053 shares over the last settlement date. Over the last 30 readings it ranged from 22 shares (13 April 2026) to 240,040 shares (27 April 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-11 | 1,538 | $5.13 | $8K |
| 2026-09-08 | 485 | $5.32 | $3K |
| 2026-09-03 | 5,051 | $5.39 | $27K |
| 2026-08-24 | 1,000 | $6.24 | $6K |
| 2026-08-20 | 3,139 | $5.89 | $18K |
| 2026-08-03 | 4,353 | $5.02 | $22K |
| 2026-07-23 | 9,359 | $5.08 | $48K |
| 2026-07-17 | 597 | $5.23 | $3K |
| 2026-06-30 | 859 | $5.18 | $4K |
| 2026-06-15 | 807 | $5.43 | $4K |
| 2026-06-12 | 13,880 | $5.49 | $76K |
| 2026-06-11 | 895 | $5.48 | $5K |
| 2026-05-29 | 3,400 | $6.47 | $22K |
| 2026-05-18 | 3,045 | $5.22 | $16K |
| 2026-05-13 | 983 | $5.47 | $5K |
| 2026-05-01 | 2,051 | $5.02 | $10K |
| 2026-04-27 | 240,040 | $4.92 | $1.2M |
| 2026-04-20 | 4,958 | $4.57 | $23K |
| 2026-04-16 | 2,133 | $4.49 | $10K |
| 2026-04-13 | 22 | $4.04 | $89 |
| 2026-04-10 | 559 | $4.05 | $2K |
| 2026-04-07 | 578 | $4.20 | $2K |
| 2026-04-06 | 2,478 | $4.15 | $10K |
| 2026-03-30 | 1,095 | $4.14 | $5K |
| 2026-03-27 | 1,481 | $4.25 | $6K |
| 2026-03-25 | 9,591 | $4.31 | $41K |
| 2026-03-17 | 12,496 | $4.55 | $57K |
| 2026-03-16 | 2,422 | $4.56 | $11K |
| 2026-03-13 | 24,810 | $4.66 | $116K |
| 2026-03-12 | 13,798 | $4.72 | $65K |
Insider trades
SEC Form 4, newest first. JSONInsiders at SRTA reported 1 open-market sell worth $29K in the last 90 days and no open-market buys. Latest filing: Wunsch Scott M (CEO, Logistics) on 2026-10-28.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-28 | Wunsch Scott M | CEO, Logistics | Tax withholding | 45K | $4.76 | $214K | 746K |
| 2026-10-28 | Wunsch Scott M | CEO, Logistics | Grant | 1K | $0.00 | $0 | 791K |
| 2026-10-28 | Wunsch Scott M | CEO, Logistics | Grant | 57K | $0.00 | $0 | 790K |
| 2026-10-28 | Wunsch Scott M | CEO, Logistics | Grant | 57K | $0.00 | $0 | 733K |
| 2026-09-24 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 91K | $5.27 | $479K | 2.2M |
| 2026-09-24 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant | 178K | $0.00 | $0 | 2.2M |
| 2026-09-24 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 98K | $5.27 | $518K | 1.8M |
| 2026-09-24 | Heyburn William A. | Co-CEO and CFO | Grant | 178K | $0.00 | $0 | 1.9M |
| 2026-09-08 | Verdetto Louis R. | CEO, Clinical Services | Tax withholding | 6K | $5.31 | $30K | 1.1M |
| 2026-09-08 | Wunsch Scott M | CEO, Logistics | Tax withholding | 6K | $5.31 | $30K | 663K |
| 2026-09-08 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 30K | $5.31 | $158K | 2.1M |
| 2026-09-08 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 32K | $5.31 | $168K | 1.7M |
| 2026-09-08 | Cohen Amir | Chief Accounting Officer | Tax withholding | 5K | $5.31 | $25K | 177K |
| 2026-08-10 | Love Reginald | Director | Sell | 5K | $5.75 | $29K | 146K |
| 2026-07-31 | Wunsch Scott M | CEO, Logistics | Tax withholding | 14K | $5.09 | $71K | 669K |
| 2026-07-31 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 212K | $5.09 | $1.1M | 2.1M |
| 2026-07-31 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 199K | $5.09 | $1.0M | 1.7M |
| 2026-07-31 | Cohen Amir | Chief Accounting Officer | Tax withholding | 34K | $5.09 | $173K | 182K |
| 2026-07-30 | Wunsch Scott M | CEO, Logistics | Grant | 3K | $0.00 | $0 | 675K |
| 2026-07-30 | Wunsch Scott M | CEO, Logistics | Grant | 10K | $0.00 | $0 | 673K |
| 2026-07-30 | WIESENTHAL ROBERT S | Director | Grant | 50K | $0.00 | $0 | 5.3M |
| 2026-07-30 | Wunsch Scott M | CEO, Logistics | Grant | 57K | $0.00 | $0 | 683K |
| 2026-07-30 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant | 207K | $0.00 | $0 | 2.3M |
| 2026-07-30 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant | 209K | $0.00 | $0 | 2.1M |
| 2026-07-30 | PHILIP EDWARD M | Director | Grant | 31K | $0.00 | $0 | 265K |
| 2026-07-30 | Love Reginald | Director | Grant | 38K | $0.00 | $0 | 152K |
| 2026-07-30 | LAUCK ANDREW | Director | Grant | 35K | $0.00 | $0 | 171K |
| 2026-07-30 | Heyburn William A. | Co-CEO and CFO | Grant | 179K | $0.00 | $0 | 1.9M |
| 2026-07-30 | Heyburn William A. | Co-CEO and CFO | Grant | 181K | $0.00 | $0 | 1.7M |
| 2026-07-30 | Cook William L. III | Director | Grant | 44K | $0.00 | $0 | 98K |
| 2026-07-30 | Cohen Amir | Chief Accounting Officer | Grant | 27K | $0.00 | $0 | 216K |
| 2026-07-30 | Cohen Amir | Chief Accounting Officer | Grant | 42K | $0.00 | $0 | 188K |
| 2026-06-08 | Wunsch Scott M | CEO, Logistics | Tax withholding | 6K | $5.87 | $33K | 626K |
| 2026-06-08 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 30K | $5.87 | $175K | 1.9M |
| 2026-06-08 | Cohen Amir | Chief Accounting Officer | Tax withholding | 5K | $5.87 | $27K | 147K |
| 2026-06-08 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 32K | $5.87 | $186K | 1.5M |
| 2026-06-08 | Tomkiel Melissa M. | Co-CEO and General Counsel | Sell | 30K | $5.87 | $175K | 1.9M |
| 2026-06-08 | Wunsch Scott M | CEO, Logistics | Sell | 6K | $5.87 | $33K | 626K |
| 2026-06-08 | Heyburn William A. | Co-CEO and CFO | Sell | 32K | $5.87 | $186K | 1.5M |
| 2026-06-08 | Cohen Amir | Chief Accounting Officer | Sell | 5K | $5.87 | $27K | 147K |
| 2026-05-22 | Cohen Amir | Chief Accounting Officer | Sell | 41K | $5.91 | $240K | 151K |
| 2026-05-21 | Cohen Amir | Chief Accounting Officer | Sell | 10K | $5.79 | $60K | 192K |
| 2026-05-11 | Cohen Amir | Chief Accounting Officer | Sell | 14K | $5.79 | $83K | 202K |
| 2026-04-24 | Wunsch Scott M | CEO, Logistics | Tax withholding | 14K | $4.92 | $68K | 631K |
| 2026-04-24 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 322K | $4.92 | $1.6M | 1.9M |
| 2026-04-24 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 302K | $4.92 | $1.5M | 1.6M |
| 2026-04-24 | Cohen Amir | Chief Accounting Officer | Tax withholding | 41K | $4.92 | $202K | 216K |
| 2026-04-23 | Wunsch Scott M | CEO, Logistics | Grant | 57K | $0.00 | $0 | 645K |
| 2026-04-23 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant | 630K | $0.00 | $0 | 2.2M |
| 2026-04-23 | Heyburn William A. | Co-CEO and CFO | Grant | 546K | $0.00 | $0 | 1.9M |
| 2026-04-23 | Cohen Amir | Chief Accounting Officer | Grant | 84K | $0.00 | $0 | 257K |
| 2026-03-16 | Wunsch Scott M | CEO, Trinity Air Medical | Grant | 18K | $0.00 | $0 | 588K |
| 2026-03-08 | Wunsch Scott M | CEO, Trinity Air Medical | Tax withholding | 4K | $4.54 | $16K | 570K |
| 2026-03-08 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 29K | $4.54 | $133K | 1.6M |
| 2026-03-08 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 31K | $4.54 | $142K | 1.3M |
| 2026-03-08 | Cohen Amir | Chief Accounting Officer | Tax withholding | 2K | $4.54 | $11K | 179K |
| 2026-02-24 | Wunsch Scott M | CEO, Trinity Air Medical | Grant | 51K | $0.00 | $0 | 573K |
| 2026-02-24 | Cohen Amir | Chief Accounting Officer | Grant | 64K | $0.00 | $0 | 182K |
| 2026-01-02 | Tomkiel Melissa M. | Co-CEO and General Counsel | Exercise or conversion | 277K | $0.18 | $50K | 1.6M |
| 2025-12-10 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 34K | $4.38 | $149K | 1.4M |
| 2025-12-10 | Wunsch Scott M | CEO, Trinity Air Medical | Tax withholding | 22K | $4.38 | $95K | 293K |
| 2025-12-10 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 35K | $4.38 | $155K | 1.4M |
| 2025-12-10 | Cohen Amir | Chief Accounting Officer | Tax withholding | 4K | $4.38 | $16K | 118K |
| 2025-12-09 | Heyburn William A. | Co-CEO and CFO | Buy | 17K | $4.47 | $76K | 1.4M |
| 2025-12-05 | LAUCK ANDREW | Director | Buy | 5K | $4.37 | $22K | 136K |
| 2025-12-02 | Wunsch Scott M | CEO, Trinity Air Medical | Grant | 13K | $0.00 | $0 | 315K |
| 2025-12-02 | Verdetto Louis R. | CEO Keystone Perfusion Service | Grant | 64K | $0.00 | $0 | 1.1M |
| 2025-12-02 | Cook William L. III | Director | Grant | 33K | $0.00 | $0 | 53K |
| 2025-12-02 | Cook William L. III | Director | Grant | 20K | $0.00 | $0 | 20K |
| 2025-11-20 | Love Reginald | Director | Sell | 11K | $4.37 | $48K | 114K |
| 2025-11-19 | Love Reginald | Director | Sell | 11K | $4.31 | $47K | 125K |
| 2025-11-07 | Tomkiel Melissa M. | Co-CEO and General Counsel | Exercise or conversion | 28K | $0.18 | $5K | 1.4M |
| 2025-11-03 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 107K | $5.03 | $536K | 1.4M |
| 2025-11-03 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 100K | $5.03 | $504K | 1.4M |
| 2025-11-03 | Cohen Amir | Chief Accounting Officer | Tax withholding | 20K | $5.03 | $103K | 121K |
| 2025-10-31 | Tomkiel Melissa M. | Co-CEO and General Counsel | Grant | 209K | $0.00 | $0 | 1.5M |
| 2025-10-31 | Heyburn William A. | Co-CEO and CFO | Grant | 181K | $0.00 | $0 | 1.5M |
| 2025-10-31 | Cohen Amir | Chief Accounting Officer | Grant | 42K | $0.00 | $0 | 142K |
| 2025-10-22 | Tomkiel Melissa M. | Co-CEO and General Counsel | Exercise or conversion | 56K | $0.18 | $10K | 1.3M |
| 2025-10-10 | Tomkiel Melissa M. | Co-CEO and General Counsel | Exercise or conversion | 56K | $0.18 | $10K | 1.2M |
| 2025-09-10 | Cohen Amir | Chief Accounting Officer | Tax withholding | 4K | $4.00 | $15K | 95K |
| 2025-09-10 | Wunsch Scott M | CEO, Trinity Air Medical | Tax withholding | 2K | $4.00 | $10K | 302K |
| 2025-09-10 | Tomkiel Melissa M. | Co-CEO and General Counsel | Tax withholding | 34K | $4.00 | $136K | 1.2M |
| 2025-09-10 | Heyburn William A. | Co-CEO and CFO | Tax withholding | 35K | $4.00 | $141K | 1.3M |
| 2025-09-10 | Cohen Amir | Chief Accounting Officer | Tax withholding | 4K | $4.00 | $15K | 100K |
| 2025-09-04 | Cohen Amir | Chief Accounting Officer | Tax withholding | 5K | $4.37 | $24K | 98K |
| 2025-08-29 | WIESENTHAL ROBERT S | Director | Grant | 41K | $0.00 | $0 | 5.3M |
| 2025-08-29 | LAUCK ANDREW | Director | Grant | 12K | $0.00 | $0 | 131K |
| 2025-08-29 | Cohen Amir | Chief Accounting Officer | Grant | 12K | $0.00 | $0 | 104K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON4 Form 144 notices on file for SRTA worth $976K at the prices reported; 1 in the last 90 days worth $517K. Latest: The Eric L. Affeldt Living Trust DTD 2/14/2005 filed on 2026-10-02 to sell 100,000 shares ($517K) from 2026-10-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-02 | The Eric L. Affeldt Living Trust DTD 2/14/2005Former Boardmember | 100K | $517K | 0.113% | 2026-10-02 | UBS Financial Services Inc |
| 2026-05-11 | AMIR COHENOfficer | 65K | $363K | 0.075% | 2026-05-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-20 | Reginald Lamonte LoveDirector | 11K | $48K | 0.013% | 2025-11-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-19 | Reginald Lamonte LoveDirector | 11K | $47K | 0.013% | 2025-11-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON10 holders report 5% or more of SRTA in their latest filing, 2 on Schedule 13D (active intent). The largest reported stake is Eric Charles Resnick at 9.0% of the class (7,923,000 shares), filed 2026-08-20 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-15 | 13D | Third Point LLCother entity | 5.1M | 5.8% | 2026-10-13 |
| 2026-10-15 | 13D | Loeb Daniel Sindividual | 5.1M | 5.8% | 2026-10-13 |
| 2026-08-20 | 13G/Ano. 3 | Eric Charles Resnickindividual | 7.9M | 9.0% | 2026-06-30 |
| 2026-08-20 | 13G/Ano. 3 | KSL Capital Partners V GP, LLCother entity | 7.9M | 9.0% | 2026-06-30 |
| 2026-08-20 | 13G/Ano. 3 | Steele ExpCo Holdings, LLCother entity | 7.9M | 9.0% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 7 | Catherine D. Woodparent holding company, individual | 2.7M | 3.2% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 7 | ARK Investment Management LLCinvestment adviser | 2.7M | 3.2% | 2026-06-30 |
| 2026-06-17 | 13G | Northern Right Capital Management, L.P.partnership, investment adviser | 4.4M | 5.1% | 2026-06-11 |
| 2026-06-17 | 13G | Matthew A. Drapkinindividual | 4.4M | 5.1% | 2026-06-11 |
| 2026-06-17 | 13G | BC Advisors LLCinvestment adviser, other entity | 4.4M | 5.1% | 2026-06-11 |
| 2026-06-17 | 13G | Northern Right Long Only Master Fund LPpartnership | 1.7M | 1.9% | 2026-06-11 |
| 2026-06-17 | 13G | Northern Right Capital (QP), L.P.partnership | 1.7M | 1.9% | 2026-06-11 |
| 2026-06-17 | 13G | Northern Right Fund GP LLCother entity | 1.7M | 1.9% | 2026-06-11 |
| 2026-05-08 | 13D/Ano. 3 | Krstic Veliborindividual, individual | 0 | 0.0% | 2026-05-07 |
| 2026-01-21 | 13G | BlackRock, Inc.parent holding company | 4.4M | 5.1% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 1 | Daniel S. Loebindividual | 5.0M | 5.8% | 2025-09-30 |
13F holders
Tracked managers holding SRTA at their latest 13F. JSON5 of the 30 tracked managers held SRTA at their latest 13F, $44.6M in total at quarter-end prices. Third Point is the largest at $26.4M (0.6% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Third Point | 2026-06-30 | 5.0M | $26.4M | 0.56% | 0 |
| ARK Investment Management | 2026-06-30 | 2.7M | $14.4M | 0.09% | -4.7M |
| Renaissance Technologies | 2026-06-30 | 492K | $2.6M | 0.00% | +18K |
| AQR Capital Management | 2026-06-30 | 140K | $736K | 0.00% | +7K |
| Point72 Asset Management | 2026-06-30 | 93K | $492K | 0.00% | +26K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Strata Critical Medical reported revenue of $72.5M, up 60.7% from the same quarter a year earlier, and net loss of $10.5M (-0.12 diluted EPS). In FY 2025 it generated -$48.9M of operating cash flow.
- Cash
- $16.3M
- Equity
- $279.3M
- Total assets
- $332.7M
- Shares outstanding
- 88,466,806
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $72.5M | -$10.5M | -14.5% | -0.12 |
| Q1 FY 2026 | 2026-03-31 | $67.4M | $2.2M | 3.2% | 0.03 |
| Q4 FY 2025derived | 2025-12-31 | $66.8M | n/a | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | $49.3M | $57.4M | 116.5% | 0.70 |
| Q2 FY 2025 | 2025-06-30 | $45.1M | -$3.7M | -8.3% | -0.05 |
| Q1 FY 2025 | 2025-03-31 | $35.9M | -$3.5M | -9.7% | -0.04 |
| Q4 FY 2024derived | 2024-12-31 | -$8.7M | n/a | n/a | n/a |
| Q3 FY 2024 | 2024-09-30 | $36.1M | -$2.0M | -5.4% | -0.03 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $197.1M | $41.3M | -$48.9M | $9.6M | $0 | n/a |
| FY 2024 | 2024-12-31 | $146.8M | -$27.3M | -$2.5M | $30.9M | $244K | n/a |
| FY 2023 | 2023-12-31 | $225.2M | -$56.1M | -$32.3M | $2.1M | $0 | n/a |
| FY 2022 | 2022-12-31 | $146.1M | -$27.3M | -$37.1M | $730K | n/a | n/a |
| FY 2021 | 2021-09-30 | $50.5M | -$40.1M | -$15.6M | $297K | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-28 from the cover page.
What this page is
Strata Critical Medical in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Strata Critical Medical (SRTA), SEC CIK 1779128, listed on Nasdaq, classified by the SEC as services-health services. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-11.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-15.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-04.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-28.JSON and CSV
- Company record
- EDGAR filing index for CIK 1779128Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-health services
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of SRTA is sold short?
What is SRTA's daily short volume?
Does SRTA have fails to deliver?
Are SRTA insiders buying or selling?
Have SRTA insiders filed to sell?
Who owns 5% or more of SRTA?
What did SRTA report last quarter?
Which tracked 13F managers own SRTA?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.